Cervi V - Search Results

1

Pharmacodynamic characteristics of low-molecular-weight dermatan sulphate after subcutaneous administration in acute myocardial infarction.

Traini AM, Cervi V, Melandri G, Palazzini E, Zamboni V, Semprini F, Candiotti N, Branzi A. Traini AM, et al. Among authors: cervi v. J Int Med Res. 1994 Nov-Dec;22(6):323-31. doi: 10.1177/030006059402200603. J Int Med Res. 1994. PMID: 7895895 Clinical Trial.

2

Effects of two dosages of subcutaneous low molecular weight heparin (Parnaparin) and of unfractionated heparin on fibrin formation and lipolysis in acute myocardial infarction.

Melandri G, Branzi A, Semprini F, Cervi V, Magnani B. Melandri G, et al. Among authors: cervi v. Thromb Res. 1992 May 1;66(2-3):141-50. doi: 10.1016/0049-3848(92)90184-c. Thromb Res. 1992. PMID: 1329251 Clinical Trial.

3

Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects.

Melandri G, Semprini F, Cervi V, Candiotti N, Branzi A, Palazzini E, Magnani B. Melandri G, et al. Among authors: cervi v. Am J Cardiol. 1993 Aug 15;72(5):450-4. doi: 10.1016/0002-9149(93)91139-9. Am J Cardiol. 1993. PMID: 8394644

4

Spontaneous superoxide generation by polymorphonuclear leukocytes isolated from patients with stable angina after physical exercise.

Guarnieri C, Melandri G, Caldarera I, Cervi V, Semprini F, Branzi A. Guarnieri C, et al. Among authors: cervi v. Int J Cardiol. 1992 Dec;37(3):301-7. doi: 10.1016/0167-5273(92)90259-6. Int J Cardiol. 1992. PMID: 1334947

5

Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin.

Melandri G, Branzi A, Semprini F, Cervi V, Galiè N, Magnani B. Melandri G, et al. Among authors: cervi v. Br Heart J. 1990 Aug;64(2):118-20. doi: 10.1136/hrt.64.2.118. Br Heart J. 1990. PMID: 2203397 Free PMC article. Clinical Trial.

6

[Chronic ischemic cardiopathy: antiplatelet agents and anticoagulants, new protocols for prevention and treatment].

Melandri G, Semprini F, Cervi V, Candiotti N, Branzi A. Melandri G, et al. Among authors: cervi v. Cardiologia. 1994 Dec;39(12 Suppl 1):347-52. Cardiologia. 1994. PMID: 7634295 Review. Italian.

7

Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris. A double-blind, randomized, placebo-controlled trial.

Melandri G, Semprini F, Cervi V, Candiotti N, Palazzini E, Branzi A, Magnani B. Melandri G, et al. Among authors: cervi v. Circulation. 1993 Dec;88(6):2517-23. doi: 10.1161/01.cir.88.6.2517. Circulation. 1993. PMID: 8252662 Clinical Trial.

8

On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes.

Melandri G, Branzi A, Traini AM, Semprini F, Cervi V, Magnani B. Melandri G, et al. Among authors: cervi v. Am J Cardiol. 1993 Feb 15;71(5):469-71. doi: 10.1016/0002-9149(93)90461-k. Am J Cardiol. 1993. PMID: 8430647 No abstract available.

9

Long-term arterial patency after coronary reperfusion.

Branzi A, Melandri G, Semprini F, Descovich B, Nanni S, Cervi V. Branzi A, et al. Among authors: cervi v. Int J Cardiol. 1999 Apr 10;68 Suppl 1:S29-33. doi: 10.1016/s0167-5273(98)00288-5. Int J Cardiol. 1999. PMID: 10328608 Review.

10

Stable and unstable angina pectoris.

Branzi A, Melandri G, Semprini F, Cervi V, Traini AM, Candiotti N, Boschi S. Branzi A, et al. Among authors: cervi v. Platelets. 1993;4(s1):23-4. doi: 10.3109/09537109309013253. Platelets. 1993. PMID: 21043685 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters